NEW YORK(GenomeWeb) – Nuclea Biotechnologies this month will launch a set of mass spectrometry assays covering roughly 55 protein biomarkers as part of its recent move into mass spec-based proteomics.

The company plans to follow that launch with the release toward the end of the year of a multiplex mass spec assay for insulin, proinsulin, and c-peptide, which it will offer as a clinical test out of the new CLIA facility it is building in Cambridge, Massachusetts.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.